MEGAN COLLETT: Open Payments
NPI 1134580145 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,542 in 152 payments from 39 companies in 2025. Trend: 2023 $1,992 · 2024 $5,498 · 2025 $2,542
Food & beverage: $2,483Education: $58
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $446 |
| PFIZER INC. | 24 | $190 |
| EMD Serono, Inc. | 5 | $168 |
| Alexion Pharmaceuticals, Inc. | 7 | $159 |
| Teva Pharmaceuticals USA, Inc. | 4 | $137 |
| CSL Behring | 4 | $105 |
| ARGENX US, INC. | 5 | $88 |
| Lilly USA, LLC | 4 | $86 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| UCB, Inc. | 4 | $78 |
Products named: QULIPTA, NURTEC ODT, ULTOMIRIS, BOTOX, Hizentra, Mavenclad, VYVGART, KESIMPTA.
Industry payments across KY — which companies pay providers there.
